Mark Wills

Dr Mark Wills

Bsc PhD MA

Mark is a Principal Research Associate based at the Department of Medicine, where his research group focus is understanding the immune response to persistent viruses.

Mark Wills

Mark studied Microbiology at the University of Surrey where he also carried out his PhD in Virology. Following a first postdoctoral position at the University of Southampton studying the immune response to cancer, he moved to the University of Cambridge in 1993 to the Department of Medicine. There he started his work on viral immunology, becoming a principal investigator.

Mark has an active research group of PhD students and postdocs focused on understanding the immune response to persistent viruses. Mark is also the Departments Biological Safety Officer and chairs the Universities Biological Safety sub-committee. He is an Editor of the Journal of General Virology and acts as external examiner at the University of Surrey on an MSc course in Medical Microbiology. He is a member of the Microbiology Society and the British Society of Immunology.




Recognitions & achievements

  • Chair of the University Biological safety sub-committee
  • Editor Journal of General Virology
  • External examiner MSc Medical Microbiology University of Surrey

Research interests

Mark's laboratory has a long-standing interest in the generation and maintenance of Human Cytomegalovirus (HCMV) specific CD4/CD8 T-cell and natural killer cells, and the role these effector cells have in the control of HCMV during long-term latent viral carriage and reactivation. Of particular interest are the mechanisms by which latent HCMV evades the immune system and is able to undergo full lytic virus reactivation but is nevertheless prevented from causing serious disease in immunocompetent individuals. Mark is funded by grants from the Medical Research Council, Welcome Trust and an industrial collaboration with GlaxoSmithKline.